Showing results (1381-1390 of 1,689) with videos related to

Sort By:
Pageof 169
The New England Journal of Medicine|December 9, 2025
Teclistamab plus Daratumumab in Relapsed or Refractory Multiple MyelomaLuciano J Costa, Nizar J Bahlis, Aurore Perrot, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 19, 2015
The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning RegimenAlvaro Urbano-Ispizua, Steven Z Pavletic, Mary E Flowers, et al.
The New England Journal of Medicine|June 5, 2023
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple MyelomaJesús San-Miguel, Binod Dhakal, Kwee Yong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2016
Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic SyndromeBrian C Shaffer, Kwang Woo Ahn, Zhen-Huan Hu, et al.
Ebiomedicine|May 28, 2019
In-depth characterization of congenital Zika syndrome in immunocompetent mice: Antibody-dependent enhancement and an antiviral peptide therapyVidyleison N Camargos, Giselle Foureaux, Daniel C Medeiros, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 20, 2014
Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphomaBaldeep Wirk, Timothy S Fenske, Mehdi Hamadani, et al.
Blood|August 1, 2025
Sequential Targeting in Multiple Myeloma: Talquetamab, a GPRC5D bispecific antibody, as a Bridge to BCMA CAR-T cell therapyBinod Dhakal, Othman Salim Akhtar, David Fandrei, et al.
BMC Biology|February 16, 2023
High SARS-CoV-2 tropism and activation of immune cells in the testes of non-vaccinated deceased COVID-19 patientsGuilherme M J Costa, Samyra M S N Lacerda, André F A Figueiredo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 20, 2016
Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple MyelomaRobert F Cornell, Anita D'Souza, Adetola A Kassim, et al.
The New England Journal of Medicine|August 22, 2019
Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple MyelomaAjai Chari, Dan T Vogl, Maria Gavriatopoulou, et al.
Pageof 169